Celgene Corporation

Celgene Corporation

Celgene Corporation

Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site
Founded
1986
Follow us
Alexa global traffic share
Twitter followers
Team Size
5000+
Employees
Xconomy

Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval

Xconomy , Reuters Top News

Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal

MedCity News

Celgene filing plans potentially mean two more CAR-Ts on the market by end of next year

Reuters Top News , GeekWire

Bristol-Myers plans to divest Celgene's psoriasis drug

Xconomy

Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout

Xconomy

Amid Acquisition Drama, Celgene Resubmits MS Drug for FDA Approval

Xconomy

The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski

Reuters Top News , MedCity News

Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal

Reuters Top News

Top Bristol-Myers shareholder comes out against $74 billion Celgene...

Xconomy

Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington

Xconomy

Starboard Ups Bristol-Myers Stake Ahead of Vote on Celgene Deal

Xconomy

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

Robotics
GeekWire

Bristol-Myers Squibb’s $74B acquisition of Juno parent Celgene puts Seattle biotech world on alert

Gründerszene

Bristol-Myers will Celgene für 74 Milliarden US-Dollar kaufen

MedCity News

Bristol-Myers Squibb to acquire Celgene in $74B deal

Xconomy

Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact

$9,000,000,000
GeekWire

Longtime Juno Therapeutics CEO Hans Bishop leaves role after merger with Celgene

Strategy Health
Bloomberg

People Are Talking About a Celgene LBO; That Should Worry It

Health Stock markets
Bloomberg

Celgene's Execution Problems Are Beyond the Pale

Health
GeekWire

Why Celgene decided to buy Juno Therapeutics for $9B — with a little help from U.S. tax reform

Health